Open AccessTolerability of budesonide/formoterol in patients of Kazakhstan rural regions
Author(s) -
Nurpeissov Tair,
Nurpeissov Temyrzhan,
Abdushukurova Gulzada,
Avdugalieva Aizhan,
Gazaliyeva Meruert,
Shagiyeva Alima
Publication year - 2015
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-5-s2-p21
Subject(s) - budesonide , medicine , tolerability , formoterol , adverse effect , asthma , budesonide/formoterol , adverse drug reaction , pediatrics , drug , pharmacology
Methods Ninety-three patients with moderate to severe uncontrolled asthma from rural outpatient clinics were included in this study. 54 women and 39 men, their age ranged from 19 to 61 years (average 35.6±4.53). None of them has ever used the combination of budesonide and formoterol before. Every subject underwent a 3-month treatment with budesonide/formoterol, daily doses of budesonide ranged from 640 to 960 mcg depending on the severity of the disease. Tolerability of budesonide/formoterol and its adverse effects occurrence were evaluated.